Abstract
AbstractThere is limited knowledge on the prevalence and risk factors of diabetic retinopathy (DR) in dialysis patients. We have investigated the association between diabetes mellitus and lipid-related biomarkers and retinopathy in hemodialysis patients. We reviewed 1,255 hemodialysis patients with type 2 diabetes mellitus (T2DM) who participated in the German Diabetes and Dialysis Study (4D Study). Associations between categorical clinical, biochemical variables and diabetic retinopathy were examined by logistic regression. On average, patients were 66 ± 8 years of age, 54% were male and the HbA1c was 6.7% ± 1.3%. DR, found in 71% of the patients, was significantly and positively associated with fasting glucose, HbA1c, time on dialysis, age, systolic blood pressure, body mass index and the prevalence of other microvascular diseases (e.g. neuropathy). Unexpectedly, DR was associated with high HDL cholesterol and high apolipoproteins AI and AII. Patients with coronary artery disease were less likely to have DR. DR was not associated with gender, smoking, diastolic blood pressure, VLDL cholesterol, triglycerides, and LDL cholesterol. In summary, the prevalence of DR in patients with type 2 diabetes mellitus requiring hemodialysis is higher than in patients suffering from T2DM, who do not receive hemodialysis. DR was positively related to systolic blood pressure (BP), glucometabolic control, and, paradoxically, HDL cholesterol. This data suggests that glucose and blood pressure control may delay the development of DR in patients with diabetes mellitus on dialysis.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Global Burden of Metabolic Risk Factors for Chronic Disease Collaboration. Cardiovascular disease, chronic kidney disease, and diabetic mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Review. Lancet Diabetes Endocrinol. 2 (8), 634–647 (2014).
2. Akmal, M. Hemodialysis in diabetic patients. Review. Am. J. Kidney Dis. 38(4 Suppl 1), 195–199 (2001).
3. U.S. Renal Data System, USRDS 2008. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available at: https://www.usrds.org/atlas08.aspx. Accessed on 12 April 2011.
4. ERA-EDTA Registry 2005. Annual Report. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands. Available at: https://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2005.pdf. Accessed on 11 June 2011.
5. Olafsdottir, E., Andersson, D. K., Dedorsson, I. & Stefansson, E. The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus. Acta Ophthalmol. 92(2), 133–137 (2014).